Search Results

You are looking at 1 - 10 of 44 items for :

  • glucose-dependent insulinotropic peptide x
  • Refine by access: All content x
Clear All
Marta Santos-Hernández Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by Marta Santos-Hernández in
Google Scholar
PubMed
Close
,
Frank Reimann Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by Frank Reimann in
Google Scholar
PubMed
Close
, and
Fiona M Gribble Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, UK

Search for other papers by Fiona M Gribble in
Google Scholar
PubMed
Close

information about dietary nutrients entering the bloodstream. The incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) play a particularly important role in glucose metabolism and regulation of food intake

Open access
Rune Ehrenreich Kuhre Department of Biomedical Sciences and NNF Center for Basic Metabolic Research, the Panum Institute, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Rune Ehrenreich Kuhre in
Google Scholar
PubMed
Close
,
Nicolai Jacob Wewer Albrechtsen Department of Biomedical Sciences and NNF Center for Basic Metabolic Research, the Panum Institute, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Nicolai Jacob Wewer Albrechtsen in
Google Scholar
PubMed
Close
,
Carolyn Fiona Deacon Department of Biomedical Sciences and NNF Center for Basic Metabolic Research, the Panum Institute, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Carolyn Fiona Deacon in
Google Scholar
PubMed
Close
,
Emilie Balk-Møller Department of Biomedical Sciences and NNF Center for Basic Metabolic Research, the Panum Institute, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Emilie Balk-Møller in
Google Scholar
PubMed
Close
,
Jens Frederik Rehfeld Department of Clinical Biochemistry Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Jens Frederik Rehfeld in
Google Scholar
PubMed
Close
,
Frank Reimann Cambridge Institute for Medical Research and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge, United Kingdom

Search for other papers by Frank Reimann in
Google Scholar
PubMed
Close
,
Fiona Mary Gribble Cambridge Institute for Medical Research and MRC Metabolic Diseases Unit, University of Cambridge, Cambridge, United Kingdom

Search for other papers by Fiona Mary Gribble in
Google Scholar
PubMed
Close
, and
Jens Juul Holst Department of Biomedical Sciences and NNF Center for Basic Metabolic Research, the Panum Institute, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Jens Juul Holst in
Google Scholar
PubMed
Close

of amidated and glycine-extended glucagon-like peptide I in humans . Diabetes 43 535 – 539 . ( doi:10.2337/diab.43.4.535 ) Parker HE Habib AM Rogers GJ Gribble FM Reimann F 2009 Nutrient-dependent secretion of glucose-dependent

Free access
Q Xiao
Search for other papers by Q Xiao in
Google Scholar
PubMed
Close
,
W Jeng
Search for other papers by W Jeng in
Google Scholar
PubMed
Close
, and
MB Wheeler
Search for other papers by MB Wheeler in
Google Scholar
PubMed
Close

Glucagon-like peptide 1 (GLP-1) is a potent insulinotropic hormone currently under study as a therapeutic agent for type 2 diabetes. Since an understanding of the molecular mechanisms leading to high-affinity receptor (R) binding and activation may facilitate the development of more potent GLP-1R agonists, we have localized specific regions of GLP-1R required for binding. The purified N-terminal fragment (hereafter referred to as NT) of the GLP-1R produced in either insect (Sf9) or mammalian (COS-7) cells was shown to bind GLP-1. The physical interaction of NT with GLP-1 was first demonstrated by cross-linking ((125)I-GLP-1/NT complex band at approximately 28 kDa) and secondly by attachment to Ni(2+)-NTA beads. The GLP-1R NT protein attached to beads bound GLP-1, but with lower affinity (inhibitory concentration (IC(50)): 4.5 x 10(-7) M) than wild-type (WT) GLP-1R (IC(50): 5.2 x 10(-9)M). The low affinity of GLP-1R NT suggested that other receptor domains may contribute to GLP-1 binding. This was supported by studies using chimeric glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptors. GIP(1-151)/GLP-1R, but not GIP(1-222)/GLP-1R, exhibited specific GLP-1 binding and GLP-1-induced cAMP production, suggesting that the region encompassing transmembrane (TM) domain 1 through to TM3 was required for binding. Since it was hypothesized that certain charged or polar amino acids in this region might be involved in binding, these residues (TM2-TM3) were analyzed by substitution mutagenesis. Five mutants (K197A, D198A, K202A, D215A, R227A) displayed remarkably reduced binding affinity. These studies indicate that the NT domain of the GLP-1R is able to bind GLP-1, but charged residues concentrated at the distal TM2/extracellular loop-1 (EC1) interface (K197, D198, K202) and in EC1 (D215 and R227) probably contribute to the binding determinants of the GLP-1R.

Free access
Vishal Musale Diabetes Research Group, School of Biomedical Sciences, Ulster University, Coleraine, Northern Ireland,

Search for other papers by Vishal Musale in
Google Scholar
PubMed
Close
,
R Charlotte Moffett Diabetes Research Group, School of Biomedical Sciences, Ulster University, Coleraine, Northern Ireland,

Search for other papers by R Charlotte Moffett in
Google Scholar
PubMed
Close
,
Bosede Owolabi Diabetes Research Group, School of Biomedical Sciences, Ulster University, Coleraine, Northern Ireland,

Search for other papers by Bosede Owolabi in
Google Scholar
PubMed
Close
,
J Michael Conlon Diabetes Research Group, School of Biomedical Sciences, Ulster University, Coleraine, Northern Ireland,

Search for other papers by J Michael Conlon in
Google Scholar
PubMed
Close
,
Peter R Flatt Diabetes Research Group, School of Biomedical Sciences, Ulster University, Coleraine, Northern Ireland,

Search for other papers by Peter R Flatt in
Google Scholar
PubMed
Close
, and
Yasser H A Abdel-Wahab Diabetes Research Group, School of Biomedical Sciences, Ulster University, Coleraine, Northern Ireland,

Search for other papers by Yasser H A Abdel-Wahab in
Google Scholar
PubMed
Close

µmol/L, stimulated the rate of insulin release from BRIN-BD11 cells ( McClenaghan et al. 1996 ) in the presence of 1.1 and 5.6 mmol/L glucose and the effect was maintained at high (16.7 mmol/L) glucose. The insulinotropic effect of the peptide was

Restricted access
Jong-Ik Hwang Graduate School of Medicine, Korea University, Seoul 136-705, Republic of Korea

Search for other papers by Jong-Ik Hwang in
Google Scholar
PubMed
Close
,
Seongsik Yun Graduate School of Medicine, Korea University, Seoul 136-705, Republic of Korea

Search for other papers by Seongsik Yun in
Google Scholar
PubMed
Close
,
Mi Jin Moon Graduate School of Medicine, Korea University, Seoul 136-705, Republic of Korea

Search for other papers by Mi Jin Moon in
Google Scholar
PubMed
Close
,
Cho Rong Park Graduate School of Medicine, Korea University, Seoul 136-705, Republic of Korea

Search for other papers by Cho Rong Park in
Google Scholar
PubMed
Close
, and
Jae Young Seong Graduate School of Medicine, Korea University, Seoul 136-705, Republic of Korea

Search for other papers by Jae Young Seong in
Google Scholar
PubMed
Close

–activity studies of glucagon-like peptide-1 . Journal of Biological Chemistry 269 6275 – 6278 . Alana I Malthouse JP O'Harte FP Hewage CM 2007 The bioactive conformation of glucose-dependent insulinotropic polypeptide by NMR and CD spectroscopy

Free access
Ahter D Sanlioglu Human Gene and Cell Therapy Center, Division of Endocrinology and Metabolism, Division of Child Neurology, Department of Urology, Akdeniz University Hospitals and Clinics, B Block, 1st floor, Campus, Antalya 07058, Turkey
Human Gene and Cell Therapy Center, Division of Endocrinology and Metabolism, Division of Child Neurology, Department of Urology, Akdeniz University Hospitals and Clinics, B Block, 1st floor, Campus, Antalya 07058, Turkey

Search for other papers by Ahter D Sanlioglu in
Google Scholar
PubMed
Close
,
Bahri Karacay Human Gene and Cell Therapy Center, Division of Endocrinology and Metabolism, Division of Child Neurology, Department of Urology, Akdeniz University Hospitals and Clinics, B Block, 1st floor, Campus, Antalya 07058, Turkey

Search for other papers by Bahri Karacay in
Google Scholar
PubMed
Close
,
Mustafa Kemal Balci Human Gene and Cell Therapy Center, Division of Endocrinology and Metabolism, Division of Child Neurology, Department of Urology, Akdeniz University Hospitals and Clinics, B Block, 1st floor, Campus, Antalya 07058, Turkey
Human Gene and Cell Therapy Center, Division of Endocrinology and Metabolism, Division of Child Neurology, Department of Urology, Akdeniz University Hospitals and Clinics, B Block, 1st floor, Campus, Antalya 07058, Turkey

Search for other papers by Mustafa Kemal Balci in
Google Scholar
PubMed
Close
,
Thomas S Griffith Human Gene and Cell Therapy Center, Division of Endocrinology and Metabolism, Division of Child Neurology, Department of Urology, Akdeniz University Hospitals and Clinics, B Block, 1st floor, Campus, Antalya 07058, Turkey

Search for other papers by Thomas S Griffith in
Google Scholar
PubMed
Close
, and
Salih Sanlioglu Human Gene and Cell Therapy Center, Division of Endocrinology and Metabolism, Division of Child Neurology, Department of Urology, Akdeniz University Hospitals and Clinics, B Block, 1st floor, Campus, Antalya 07058, Turkey
Human Gene and Cell Therapy Center, Division of Endocrinology and Metabolism, Division of Child Neurology, Department of Urology, Akdeniz University Hospitals and Clinics, B Block, 1st floor, Campus, Antalya 07058, Turkey

Search for other papers by Salih Sanlioglu in
Google Scholar
PubMed
Close

patients with T2D ( Dejager & Schweizer 2012 ). GLP1 is naturally released from the gut into circulation after a meal. Because natural peptide forms of GLP1 and glucose-dependent insulinotropic peptide (GIP; incretins) are quickly destroyed by dipeptidyl

Free access
Dennis Brüning Institute of Pharmacology and Toxicology, University of Braunschweig, Braunschweig, Germany

Search for other papers by Dennis Brüning in
Google Scholar
PubMed
Close
,
Kirstin Reckers Institute of Pharmacology and Toxicology, University of Braunschweig, Braunschweig, Germany

Search for other papers by Kirstin Reckers in
Google Scholar
PubMed
Close
,
Peter Drain Department of Cell Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Search for other papers by Peter Drain in
Google Scholar
PubMed
Close
, and
Ingo Rustenbeck Institute of Pharmacology and Toxicology, University of Braunschweig, Braunschweig, Germany

Search for other papers by Ingo Rustenbeck in
Google Scholar
PubMed
Close

subsequent KCl effect. The insulinotropic effect of KCl was not significantly different when preceding or following the glucose stimulation ( Fig. 1A ). Figure 1 Insulinotropic effect of successive stimulation with 40 mM KCl and 30 mM glucose at 37°C

Free access
Hongjie Zhang State Key Laboratory of Pharmaceutical Biotechnology, First Affiliated Hospital of Nanjing Medical University, School of Biological Sciences, Jiangsu Diabetes Center, Nanjing University, Nanjing, Jiangsu 210093, People's Republic of China
State Key Laboratory of Pharmaceutical Biotechnology, First Affiliated Hospital of Nanjing Medical University, School of Biological Sciences, Jiangsu Diabetes Center, Nanjing University, Nanjing, Jiangsu 210093, People's Republic of China

Search for other papers by Hongjie Zhang in
Google Scholar
PubMed
Close
,
Jing Li State Key Laboratory of Pharmaceutical Biotechnology, First Affiliated Hospital of Nanjing Medical University, School of Biological Sciences, Jiangsu Diabetes Center, Nanjing University, Nanjing, Jiangsu 210093, People's Republic of China

Search for other papers by Jing Li in
Google Scholar
PubMed
Close
,
Xiangying Liang State Key Laboratory of Pharmaceutical Biotechnology, First Affiliated Hospital of Nanjing Medical University, School of Biological Sciences, Jiangsu Diabetes Center, Nanjing University, Nanjing, Jiangsu 210093, People's Republic of China

Search for other papers by Xiangying Liang in
Google Scholar
PubMed
Close
,
Yun Luo State Key Laboratory of Pharmaceutical Biotechnology, First Affiliated Hospital of Nanjing Medical University, School of Biological Sciences, Jiangsu Diabetes Center, Nanjing University, Nanjing, Jiangsu 210093, People's Republic of China

Search for other papers by Yun Luo in
Google Scholar
PubMed
Close
,
Ke Zen State Key Laboratory of Pharmaceutical Biotechnology, First Affiliated Hospital of Nanjing Medical University, School of Biological Sciences, Jiangsu Diabetes Center, Nanjing University, Nanjing, Jiangsu 210093, People's Republic of China

Search for other papers by Ke Zen in
Google Scholar
PubMed
Close
, and
Chen-Yu Zhang State Key Laboratory of Pharmaceutical Biotechnology, First Affiliated Hospital of Nanjing Medical University, School of Biological Sciences, Jiangsu Diabetes Center, Nanjing University, Nanjing, Jiangsu 210093, People's Republic of China

Search for other papers by Chen-Yu Zhang in
Google Scholar
PubMed
Close

. 1964 , McIntyre et al . 1965 , Perley & Kipnis 1967 ). This is mainly attributed to two hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP1) ( McIntyre et al . 1964 , Thorens 1995 ). GLP1 is a product of

Free access
Maria Sörhede Winzell Division of Medicine, Department of Clinical Sciences, Lund University, BMC, B11, SE-221 84 Lund, Sweden

Search for other papers by Maria Sörhede Winzell in
Google Scholar
PubMed
Close
and
Bo Ahrén Division of Medicine, Department of Clinical Sciences, Lund University, BMC, B11, SE-221 84 Lund, Sweden

Search for other papers by Bo Ahrén in
Google Scholar
PubMed
Close

insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic β-cells . Hormone and Metabolic Research 36 787 – 794 . Hui H Nourparvar A Zhao X Perfetti R 2003 Glucagon-like peptide-1 inhibits

Free access
Riccarda Granata Laboratory of Molecular, Division of Endocrinology, Cellular Endocrinology and Metabolism
Laboratory of Molecular, Division of Endocrinology, Cellular Endocrinology and Metabolism

Search for other papers by Riccarda Granata in
Google Scholar
PubMed
Close
,
Alessandra Baragli Laboratory of Molecular, Division of Endocrinology, Cellular Endocrinology and Metabolism
Laboratory of Molecular, Division of Endocrinology, Cellular Endocrinology and Metabolism

Search for other papers by Alessandra Baragli in
Google Scholar
PubMed
Close
,
Fabio Settanni Laboratory of Molecular, Division of Endocrinology, Cellular Endocrinology and Metabolism
Laboratory of Molecular, Division of Endocrinology, Cellular Endocrinology and Metabolism

Search for other papers by Fabio Settanni in
Google Scholar
PubMed
Close
,
Francesca Scarlatti Laboratory of Molecular, Division of Endocrinology, Cellular Endocrinology and Metabolism
Laboratory of Molecular, Division of Endocrinology, Cellular Endocrinology and Metabolism

Search for other papers by Francesca Scarlatti in
Google Scholar
PubMed
Close
, and
Ezio Ghigo Laboratory of Molecular, Division of Endocrinology, Cellular Endocrinology and Metabolism

Search for other papers by Ezio Ghigo in
Google Scholar
PubMed
Close

. In addition, the existence of common receptor(s) for the three peptides has been suggested. In the case of Ob-induced cAMP elevation, the cAMP-dependent enzyme PKA phosphorylates and activates the transcription factor CREB. The effect of AG and UAG on

Free access